{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:50:22Z","timestamp":1785873022689,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cca.2026.120905","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:39:16Z","timestamp":1771000756000},"page":"120905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups"],"prefix":"10.1016","volume":"586","author":[{"given":"Nazmin","family":"Bithi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Dowlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2026.120905_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70132","article-title":"Metabolic dysfunction-associated Steatotic liver disease (MASLD): mechanisms, clinical implications and therapeutic advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.cca.2026.120905_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1675713","article-title":"The evolving landscape of pediatric obesity and metabolic dysfunction-associated steatotic liver disease","volume":"13","author":"Putri","year":"2025","journal-title":"Front. Pediatr."},{"issue":"5","key":"10.1016\/j.cca.2026.120905_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/metabo15050299","article-title":"Metabolic dysfunction-associated Steatotic liver disease in the Korean general population: epidemiology, risk factors, and non-invasive screening","volume":"15","author":"Choi","year":"2025","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.cca.2026.120905_bb0020","article-title":"Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD","volume":"135","author":"Lauridsen","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cca.2026.120905_bb0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12876-025-04079-4","article-title":"Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank","volume":"25","author":"Feng","year":"2025","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2026.120905_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.advms.2023.12.001","article-title":"Liver fibrosis assessment in pediatric population-can ultrasound elastography be an alternative method to liver biopsy? A systematic review","volume":"69","author":"Medy\u0144ska-Prz\u0119czek","year":"2024","journal-title":"Adv. Med. Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.120905_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.diii.2017.03.003","article-title":"Liver fibrosis, cirrhosis, and cirrhosis-related nodules: imaging diagnosis and surveillance","volume":"98","author":"Aub\u00e9","year":"2017","journal-title":"Diagn. Interv. Imaging"},{"key":"10.1016\/j.cca.2026.120905_bb0040","series-title":"Hepatic Medicine: Evidence and Research","first-page":"59","article-title":"The Need for Alternatives to Liver Biopsies: Non-invasive Analytics and Diagnostics","author":"Neuberger","year":"2021"},{"key":"10.1016\/j.cca.2026.120905_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","article-title":"Non-invasive testing and risk-stratification in patients with MASLD","volume":"122","author":"Zoncap\u00e8","year":"2024","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120905_bb0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12876-021-02038-3","article-title":"FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran","volume":"21","author":"Amernia","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"13","key":"10.1016\/j.cca.2026.120905_bb0055","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/diagnostics15131575","article-title":"Evaluating the discriminative performance of noninvasive biomarkers in chronic hepatitis B\/C, alcoholic cirrhosis, and nonalcoholic cirrhosis: a comparative analysis","volume":"15","author":"Dumitrache","year":"2025","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.cca.2026.120905_bb0060","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.38346","article-title":"Fibroscan compared to FIB-4, APRI, and AST\/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease","volume":"16","author":"Fallatah","year":"2016","journal-title":"Hepat. Mon."},{"issue":"47","key":"10.1016\/j.cca.2026.120905_bb0065","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.3748\/wjg.v30.i47.5070","article-title":"Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Yodoshi","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2026.120905_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00431-024-05848-1","article-title":"Pediatric MASLD: current understanding and practical approach","volume":"184","author":"Stroes","year":"2024","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.cca.2026.120905_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jpn3.12068","article-title":"Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease","volume":"78","author":"Kalveram","year":"2024","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"9","key":"10.1016\/j.cca.2026.120905_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70281","article-title":"Diagnostic performance of Fibrosis-4 index, nonalcoholic fatty liver disease fibrosis score, AST-to-platelet ratio index, and BARD score among young and older adults for the diagnosis of advanced MASLD fibrosis: a retrospective cohort study","volume":"9","author":"Lin","year":"2025","journal-title":"JGH Open"},{"issue":"9","key":"10.1016\/j.cca.2026.120905_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0333581","article-title":"Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients","volume":"20","author":"Al Mazrouei","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.120905_bb0090","article-title":"FIB-4 turns 20: a lesson of serendipity","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cca.2026.120905_bb0105","first-page":"117","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin. Biochem. Rev."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:28:22Z","timestamp":1784017702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":19,"alternative-id":["S0009898126000872"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120905","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120905"}}